Safety and Immunogenicity of a Plant-Produced Recombinant Hemagglutinin-Based Influenza Vaccine (HAI-05) Derived from A/Indonesia/05/2005 (H5N1) Influenza Virus: A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study in Healthy Adults
Chichester, Jessica, Jones, R., Green, Brian, Stow, Mark, Miao, Fudu, Moonsammy, George, Streatfield, Stephen, Yusibov, VidadiVolume:
4
Language:
english
Journal:
Viruses
DOI:
10.3390/v4113227
Date:
November, 2012
File:
PDF, 347 KB
english, 2012